Efficacy and safety of galcanezumab for the prevention of episodic migraine: Results of the EVOLVE-2 Phase 3 randomized controlled clinical trial

Skljarevski, V; Matharu, M; Millen, BA; Ossipov, MH; Kim, B-K; Yang, JY; (2018) Efficacy and safety of galcanezumab for the prevention of episodic migraine: Results of the EVOLVE-2 Phase 3 randomized controlled clinical trial. Cephalalgia , 38 (8) pp. 1442-1454. 10.1177/0333102418779543 . Green open access

https://ift.tt/2SQjKXs